Medigen Biotechnology Corp. (TPEX:3176)

Medigen Biotechnology Revenue

In the year 2025, Medigen Biotechnology had annual revenue of 1.58B TWD with 15.28% growth. Medigen Biotechnology had revenue of 326.68M in the quarter ending December 31, 2025, a decrease of -1.20%.

• Revenue: 1.58B
• Revenue Growth: +15.28%
• P/S Ratio: 2.93
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.58B	209.80M	15.28%
Dec 31, 2024	1.37B	214.98M	18.57%
Dec 31, 2023	1.16B	101.77M	9.64%
Dec 31, 2022	1.06B	-2.87B	-73.08%
Dec 31, 2021	3.92B	3.31B	537.17%